The Thai Phase III Trial (RV144) Vaccine Regimen Induces T Cell Responses That Preferentially Target Epitopes within the V2 Region of HIV-1 Envelope
Mark de Souza, Doris Thelian(Walter Reed Army Institute of Research), P Thongcharoen(Mahidol University), Viseth Ngauy(Walter Reed Army Institute of Research), Bessara Nuntapinit, Michael W. Benenson(Armed Forces Research Institute of Medical Science), Weerawan Chuenarom(Armed Forces Research Institute of Medical Science), Wirach Maek-a-nantawat, Supamit Chunsuttiwat(Ministry of Public Health), Chawetsan Namwat(Mahidol University), Jeffrey R. Currier(Walter Reed Army Institute of Research), Jittima Dhitavat, Valai Bussaratid, Silvia Ratto‐Kim(Walter Reed Army Institute of Research), Nelson L. Michael(Walter Reed Army Institute of Research), Pawinee Jarujareet(Armed Forces Research Institute of Medical Science), Patricia Morgan, Somsak Chantakulkij(Armed Forces Research Institute of Medical Science), Punnee Pitisuttithum(Mahidol University), Jaranit Kaewkunwal, Nakorn Premsri, Jaranit Kaewkungwal(Mahidol University), Rapee Trichavaroj, Pravan Suntharasamai(Mahidol University), Sorachai Nitayaphan(Royal Thai Army), Robert Paris(GlaxoSmithKline (United States)), Anais Valencia-Micolta(Walter Reed Army Institute of Research), Amnat Khamsiriwatchara, Swangjai Pungpak, Mary Marovich(University of Maryland, Baltimore), Alexandra Schuetz(Armed Forces Research Institute of Medical Science), Chirapa Easmila, Nusara Thaitawat(United States Department of the Army), Supachai Rerks‐Ngarm(Ministry of Public Health), Bonnie J. Mathieson(National Institute of Allergy and Infectious Diseases), Chirasak Khamboonruang(Mahidol University), Prayura Kunasol(Mahidol University), Arthur E. Brown(Memorial Sloan Kettering Cancer Center), Siriwan Vanijanonta(Mahidol University), Jérôme H. Kim(International Vaccine Institute), Suchana Tabprasit
Cited by 140
Related Papers
Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
|New England Journal of Medicine|2009|3k
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
|New England Journal of Medicine|2021|2.6k
Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase
|New England Journal of Medicine|2021|661
Risk Factors for Perinatal Transmission of Human Immunodeficiency Virus Type 1 in Women Treated with Zidovudine
|New England Journal of Medicine|1999|553